Entries by mercuric

NCRI 2016

MErCuRIC results were presented in a poster at the NCRI Cancer Conference in Liverpool, UK on 08 Nov 2016 (Session B, 08:15-11:00). The conference ‘showcases the latest basic, translational and clinical cancer research. It brings researchers together to share ideas and develop collaborations.’ ‘MErCuRIC1: A Phase Ia study of MEK1/2 inhibitor PD-0325901 with cMET inhibitor crizotinib in patients with advanced […]

EUPATI Oct 2016 Newsletter

The latest newsletter from EUPATI is now available. This issue covers an update on national activities in 18 countries and information on the upcoming EUPATI 2016 conference All Aboard to a Better Health Future on 14 Dec 2016.

MErCuRIC at ESMO16

The MErCuRIC Phase I trial was presented at the ESMO 2016 Congress in Copenhagen (7 – 11 Oct 2016). MErCuRIC1: A phase 1a study of MEK1/2 inhibitor PD-0325901 with cMET inhibitor crizotinib in patients with advanced solid tumours (Poster: 480P) R. Wilson, M. Middleton, J. Houlden, S. Van Schaeybroeck, C. Rolfo, E. Elez, J. Taieb , […]

Video on Liquid Biopsies from UNITO

Technologies to isolate and analyse liquid biopsy samples are rapidly evolving. MErCuRIC researcher Federica Di Nicolantonio discusses the technique in this video produced with ESMO.

EUPATI Summer 2016 Newsletter

The summer 2016 newsletter for the European Patients’ Academy (EUPATI) is now available. In this issue, you can access the Patient Expert Training Course, now available in English, as well as learn about the growing national EUPATI teams that function as patient involvement groups locally.

MErCuRIC members serving the interests of upcoming young talents in oncology – the future of our profession

While the ever-advancing landscape of precision medicine in oncology undoubtedly brings fresh hope for patients, it also poses many yet unanswered questions as to how we move forward, without the real risk of burn-out of those who treat them – particularly with regards to the up-and- coming generation of young oncologists, the future of our profession and practice. Established […]

Delivering 21st Century Medicine for bowel cancer patients

In June 2016, the Northern Ireland Cancer Research Consumer Forum and its Bowel Cancer Research Interest Group hosted a public event – ‘Delivering 21st Century Medicine for bowel cancer patients’. A MErCuRIC poster was displayed at the event in Belfast. The event was opened by a member of the Local Assembly and speakers included MErCuRIC researcher […]

ASCO 2016 Meeting

MErCuRIC researchers from RCSI, BHSCT, QUB and PDUM presented results from their other research projects in colorectal cancer at the American Society of Clinical Oncology (ASCO) 2016 Annual meeting in Chicago, 03 – 07 June. A systems model of BCL-2 dependent apoptosis to predict stage II CRC patients benefiting from adjuvant chemotherapy and as a […]

Public Event on Bowel Cancer in Belfast

On 29 June 2016, MErCuRIC partners from BHSCT and QUB will participate in a free public event on bowel cancer. Prof. Mark Lawler (QUB) will speak at the event, which will include patients, advocates and researchers as attendees.